SSAA09E2
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1].
Product Specifications
CAS Number
[883944-52-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ssaa09e2.html
Purity
98.37
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1=CC=NO1)NCC2=CC=C(N3CCN(C)CC3)C=C2
Molecular Formula
C16H20N4O2
Molecular Weight
300.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal ISG15/UCRP Antibody (239) [DyLight 405]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
sc-346541 1 g
(3-benzyl-7-isobutyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl) acetic acid
Ask
View Details MBS1391924-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Phosphoribosylglycinamide formyltransferase (purN)
Ask
View Details MBS1391924-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Phosphoribosylglycinamide formyltransferase (purN)
Ask
View Details 
MBS1391924-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Phosphoribosylglycinamide formyltransferase (purN)
Ask
View Details